Sensydia Announces American Medical Association Category III CPT® Code for Noninvasive AI Hemodynamic Assessment
/Groundbreaking code will facilitate use, adoption, and pathway for reimbursement of AI-based hemodynamic assessment, including Sensydia's Cardiac Performance System (CPS™).
LOS ANGELES, Jan. 6, 2026 /PRNewswire/ -- Sensydia, a medical technology company advancing non-invasive cardiac assessment, today announced that the American Medical Association (AMA) has published a new industry-first Category III CPT® code, 1036T, for noninvasive augmentative AI hemodynamic assessment, encompassing Sensydia's Cardiac Performance System (CPS™). The new CPT code was published December 30, 2025, and will be effective July 1, 2026.
"Publication of the new AMA CPT code represents a significant milestone for Sensydia, and will help foster the adoption of our noninvasive, in-clinic hemodynamic assessment tool by establishing a pathway for reimbursement," said Anthony Arnold, CEO of Sensydia.